Why do promising preclinical drugs fail in clinical trials? From a trade-off framework to higher-fidelity models

hLife · Published 2026-07-01 · DOI 10.1016/j.hlife.2026.06.005

Free full text

Authors (3)

Bo-Wen Zhou, Ding-Jun Jin, Ya-Ping Zhang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Zhou, B., Jin, D., Zhang, Y. (2026). Why do promising preclinical drugs fail in clinical trials? From a trade-off framework to higher-fidelity models. hLife. https://doi.org/10.1016/j.hlife.2026.06.005

Related articles